SREBF2 and hepatocellular carcinoma: Conversely, impaired SREBP2 maturation and suppressed cholesterol biosynthesis inhibit HCC cell proliferation, which is associated with a favorable prognosis in HCC patients (Feng et al., 2017; Liang et al., 2019; Xiang et al., 2022; He et al., 2024).